UT Southwestern Medical Center in Dallas has secured the top global position for healthcare research according to the Nature Index. The ranking covers the twelve-month period concluding on February 28, 2026. The institution also led healthcare entities worldwide in the natural sciences and biological sciences during this timeframe.
The Nature Index monitors research articles published in leading science journals to gauge high-quality discoveries. It evaluated data from 6,545 institutions globally. For UT Southwestern, the ranking period included over 500 research papers published in nearly 100 journals. These publications appeared in outlets such as Nature, Science, Circulation, and The Journal of the American Medical Association.
The cited research spans multiple medical fields. Studies included in the ranking examined the effects of GLP-1 medications, methods for reprogramming heart cells to restore function after a heart attack, and fibroblast populations that drive cancer progression. Other work explored how different parts of the brain's hippocampus support memory.
UT Southwestern also ranked first among 1,192 healthcare institutions in North America and 995 entities in the United States during the same period.
Joan Conaway, Ph.D., Vice Provost and Dean of Basic Research at UT Southwestern, stated that the ranking reflects the depth and excellence of the institution's research enterprise. She noted that scientists are working to advance knowledge across disciplines to better understand diseases and translate insights into patient progress. W. P. Andrew Lee, M.D., Executive Vice President for Academic Affairs, Provost, and Dean of UT Southwestern Medical School, added that the recognition highlights the sustained efforts of faculty and trainees. He emphasized that supporting rigorous research and collaboration allows the institution to translate discoveries into real-world impact.
The medical center supports approximately 6,200 research projects annually across more than one million square feet of research space. It receives over $816 million in annual funding from state and federal agencies, as well as individuals and corporations. Its research portfolio includes the Harold C. Simmons Comprehensive Cancer Center and the Peter O’Donnell Jr. Brain Institute. The institution also hosts one of only 11 Nutrition Obesity Research Centers in the country and a National Organization for Rare Disorders Rare Disease Center of Excellence. Additionally, it is designated as a National Cancer Institute Specialized Program of Research Excellence site for liver, lung, and kidney cancer.
